Penobscot Investment Management Company Inc. Has $2.73 Million Position in Agilent Technologies, Inc. (NYSE:A)

Penobscot Investment Management Company Inc. decreased its position in shares of Agilent Technologies, Inc. (NYSE:A) by 5.1% during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 20,305 shares of the medical research company’s stock after selling 1,085 shares during the quarter. Penobscot Investment Management Company Inc.’s holdings in Agilent Technologies were worth $2,728,000 as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of A. CKW Financial Group boosted its stake in shares of Agilent Technologies by 114.9% in the 4th quarter. CKW Financial Group now owns 187 shares of the medical research company’s stock valued at $25,000 after purchasing an additional 100 shares during the last quarter. Global X Japan Co. Ltd. boosted its stake in Agilent Technologies by 161.1% in the fourth quarter. Global X Japan Co. Ltd. now owns 188 shares of the medical research company’s stock valued at $25,000 after acquiring an additional 116 shares during the last quarter. Lee Danner & Bass Inc. acquired a new stake in Agilent Technologies during the 4th quarter worth $29,000. Hanson & Doremus Investment Management raised its position in shares of Agilent Technologies by 66.5% during the 4th quarter. Hanson & Doremus Investment Management now owns 263 shares of the medical research company’s stock valued at $35,000 after acquiring an additional 105 shares during the last quarter. Finally, OFI Invest Asset Management acquired a new position in shares of Agilent Technologies in the 4th quarter valued at $37,000.

Agilent Technologies Trading Down 1.3 %

NYSE A opened at $120.35 on Wednesday. Agilent Technologies, Inc. has a 52 week low of $117.17 and a 52 week high of $155.35. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.66 and a current ratio of 2.20. The stock’s 50 day moving average price is $135.88 and its two-hundred day moving average price is $137.05. The stock has a market capitalization of $34.31 billion, a price-to-earnings ratio of 27.67, a PEG ratio of 3.42 and a beta of 1.11.

Agilent Technologies (NYSE:A) last announced its quarterly earnings data on Wednesday, February 26th. The medical research company reported $1.31 EPS for the quarter, topping analysts’ consensus estimates of $1.27 by $0.04. The business had revenue of $1.68 billion for the quarter, compared to analyst estimates of $1.67 billion. Agilent Technologies had a net margin of 19.27% and a return on equity of 25.56%. As a group, analysts anticipate that Agilent Technologies, Inc. will post 5.57 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, April 23rd. Investors of record on Tuesday, April 1st will be given a $0.248 dividend. This represents a $0.99 dividend on an annualized basis and a dividend yield of 0.82%. The ex-dividend date is Tuesday, April 1st. Agilent Technologies’s dividend payout ratio is currently 22.76%.

Analyst Ratings Changes

A number of equities research analysts recently commented on the company. Barclays raised Agilent Technologies from an “underweight” rating to an “equal weight” rating and lifted their price objective for the stock from $135.00 to $145.00 in a research note on Monday, February 10th. Citigroup upped their price target on Agilent Technologies to $165.00 and gave the company a “buy” rating in a research note on Thursday, December 19th. Robert W. Baird reduced their price objective on shares of Agilent Technologies from $161.00 to $159.00 and set an “outperform” rating on the stock in a research note on Thursday, February 27th. Bank of America lowered their target price on shares of Agilent Technologies from $153.00 to $150.00 and set a “neutral” rating for the company in a research note on Friday, December 13th. Finally, JPMorgan Chase & Co. reduced their price target on shares of Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating on the stock in a research report on Tuesday, November 26th. Seven equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. According to MarketBeat, Agilent Technologies has an average rating of “Moderate Buy” and a consensus target price of $146.15.

Insider Buying and Selling

In other Agilent Technologies news, VP Rodney Gonsalves sold 1,908 shares of the business’s stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $121.98, for a total transaction of $232,737.84. Following the transaction, the vice president now owns 21,786 shares of the company’s stock, valued at $2,657,456.28. The trade was a 8.05 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CEO Padraig Mcdonnell sold 1,911 shares of the stock in a transaction that occurred on Tuesday, January 21st. The shares were sold at an average price of $150.00, for a total value of $286,650.00. Following the completion of the sale, the chief executive officer now directly owns 39,652 shares of the company’s stock, valued at approximately $5,947,800. The trade was a 4.60 % decrease in their position. The disclosure for this sale can be found here.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.